Wireless Medical-device Market Access — RED, FCC and International Radio Approvals

A wireless device has a parallel market-access path

A medical device that deliberately transmits or receives radio signals may need more than medical-device conformity. Radio-spectrum, electromagnetic-compatibility, electrical-safety, exposure, cybersecurity, labelling and national market-access rules can apply in parallel.

The useful question is not simply “Is the module approved?” It is: which complete product configuration may be placed on each intended market, under which radio rules, with what evidence and continuing controls?

Use MTL-111 — Data, Connectivity and Interoperability for system behaviour and MTL-117 — Electrical Safety and Electromagnetic Compatibility for the wider safety and EMC evidence.

Freeze the radio definition before selecting an approval route

Approvals attach to a defined radio product or authorised module used within stated conditions. Small product changes can alter the regulatory position, so the radio configuration should be treated as controlled design data.

• Identify every transmitter, receiver and radio technology, including service and optional functions.
• Define frequency bands, channel bandwidths, modulation, duty cycle and maximum conducted power.
• Identify the antenna type, gain, placement, cable and available alternatives.
• Define simultaneous transmission, collocation and worst-case operating modes.
• Describe the enclosure, shielding, grounding, host processor and power configuration.
• State the separation from patients, users and bystanders needed for exposure assessment.
• Control the firmware, regional settings and commands that can change radio behaviour.

The complete definition should connect to MTL-105 — Systems Engineering, Architecture and Interfaces and the released bill of materials.

Build a market matrix early

Start with every country in the commercial plan. For each market, identify the authority, legal basis, authorisation route, local representative or applicant, test standards, recognised reports, labelling, database listing, language, retention period and renewal or surveillance obligations.

Do not copy a prior product's route without checking the current law, frequency allocation and product configuration. Radio rules and accepted standards can change independently of medical-device requirements.

European Union — apply the Radio Equipment Directive

Directive 2014/53/EU establishes the EU framework for placing radio equipment on the market. Its core essential requirements address health and safety, electromagnetic compatibility and effective and efficient use of radio spectrum. Other activated requirements can address privacy, personal data, fraud, interoperability, emergency services and combinations of radio equipment and software.

The manufacturer identifies applicable requirements, selects the conformity-assessment procedure, compiles technical documentation, draws up the EU declaration of conformity and applies CE marking. Harmonised standards can provide a presumption of conformity within their scope; deviations, limitations and standards not cited in the Official Journal need a defensible evidence strategy. A notified body may be required by the selected route or where the harmonised-standards conditions for the spectrum requirement are not met.

EU radio cybersecurity is currently transitional: Delegated Regulation (EU) 2022/30 has applied since August 2025, while Delegated Regulation (EU) 2026/339 repeals it from 11 December 2027 as the main Cyber Resilience Act obligations apply. Determine scope for the actual product and date; do not treat medical-device cybersecurity evidence as an automatic substitute for RED conformity.

Use MTL-301 — EU MDR and IVDR General Safety and Performance Requirements to keep RED evidence aligned with the device's wider EU technical documentation.

Great Britain and Northern Ireland require a deliberate route

Great Britain's Radio Equipment Regulations 2017 set requirements for radio equipment placed on the GB market. They address safety, EMC and protection of the radio spectrum and require technical documentation, conformity assessment, an applicable declaration, marking and continuing production conformity.

Current GB guidance recognises CE-marked goods meeting specified EU requirements for many product sectors and also describes UKCA routes. Northern Ireland operates under different arrangements. Record the market, marking route, responsible parties and applicable guidance rather than describing one undifferentiated “UK approval”.

United States — classify the device under FCC rules

FCC equipment-authorisation requirements apply before regulated radio-frequency devices are marketed or imported into the United States. The route depends on the device type and applicable rule part. Intentional transmitters commonly require Certification; other equipment may follow Supplier's Declaration of Conformity where the rules permit it.

• Identify the applicable rule parts, operating bands and technical limits.
• Confirm whether the end product, an installed module or both require authorisation work.
• Use an appropriately recognised test laboratory and Telecommunications Certification Body where Certification applies.
• Assess radio-frequency exposure for the intended use, separation and simultaneous transmitters.
• Control the FCC identifier, compliance information, user statements and electronic labelling where used.
• Check grant conditions, modular-integration instructions and limitations before design freeze.
• Assess permissive-change or new-authorisation implications before changing hardware, antenna or radio firmware.

FCC compliance and FDA review have different purposes. FDA also expects wireless medical-device evidence addressing selection of wireless technology, quality of service, coexistence, EMC, security and the consequences of communication failure. Connect that work to MTL-302 — US FDA Medical-device Regulations — 21 CFR Overview.

Other countries are not covered by CE or FCC

Canada, Japan, Australia, New Zealand, Switzerland and many other markets operate their own radio regimes. Some accept foreign test reports or use standards related to EU or US methods; others require a local applicant, recognised laboratory, national identifier, database registration, sample, translated documentation or country-specific test.

Complete the market matrix before launch commitments. Confirm permitted bands and power limits, because a radio configuration legal in one country may not be legal in another. Regional firmware controls must be robust enough to prevent prohibited configurations and must remain within the assessed product.

Separate legal approvals from industry qualifications

Wireless technologies can add contractual or ecosystem requirements. A Bluetooth product must complete the Bluetooth SIG qualification process before it is sold or distributed as a Bluetooth product. Cellular devices may also need GCF or PTCRB certification and network-operator acceptance. Wi-Fi branding and other technology marks have their own programme rules.

These qualifications may be commercially necessary but do not replace government radio authorisation or medical-device conformity. Put each obligation in the same launch plan so ownership, samples, fees and lead times are visible.

An approved radio module reduces work—it does not remove responsibility

A modular approval can allow the host manufacturer to rely on part of the module's evidence when every condition of the grant and integration instruction is met. Confirm the exact module version, antennas, host layout, separation, shielding, power, collocation, software restrictions and required host labelling.

The host product may still need unintentional-emissions testing, exposure assessment, simultaneous-transmission evaluation, additional transmitter testing and market-specific documentation. A custom antenna, altered shielding, new power amplifier, radio firmware change or integration outside the approved conditions can require further evaluation or a new authorisation.

Supplier documentation should be a controlled input under MTL-123 — Supplier and Outsourced-process Control, with access to grants, reports, integration instructions, declarations, change notices and lifecycle status.

Integrate radio evidence with medical-device safety and performance

Passing transmitter limits does not establish that the medical device communicates safely in its intended environment. Define the clinical and operational consequences of delay, corruption, congestion, disconnection, interference, unexpected pairing and loss of infrastructure.

Use MTL-109 — Medical-device Cybersecurity and MTL-114 — Medical-device Risk Management to build the connected evidence.

Run approvals as a controlled development programme

Create an approval plan with dependencies and decision gates. Book representative samples and competent laboratories early, especially when multiple radio modes, antennas, product variants or markets must be covered. Resolve failures through controlled design change, documented root cause and appropriate regression.

Control the authorised configuration throughout the lifecycle

Radio compliance can be affected by changes that appear minor to the product team: a substitute module, antenna, enclosure material, shielding gasket, cable, PCB stack-up, clock, power converter, radio library, regional setting or transmit duty cycle.

• Maintain a baseline that links each market authorisation to hardware, software, antenna, labels and reports.
• Require suppliers to notify relevant component, firmware, manufacturing-site and certificate changes.
• Include radio, exposure, EMC, coexistence and labelling impact in engineering change review.
• Determine whether analysis, supplementary testing, a permissive change, certificate update or new approval is required.
• Control database listings, declarations and customer documentation with the released configuration.
• Monitor regulatory and standards changes for supported markets.

MTL-129 — Configuration and Change Management explains how to make these decisions traceable.

Common misconceptions

Practical readiness checklist

• Are all intended markets and launch dates listed?
• Is every radio technology, antenna, power level, mode and variant controlled?
• Have national radio rules and permitted spectrum been confirmed?
• Is the selected approval route justified for every market?
• Are module grant conditions and integration instructions satisfied?
• Do plans cover exposure, EMC, coexistence, cybersecurity and communication failure?
• Are formal samples representative of the released configuration?
• Are declarations, grants, identifiers, labels and user statements complete?
• Are Bluetooth, cellular, carrier or other ecosystem obligations planned separately?
• Can supplier and product changes be assessed against every affected approval?
• Does the technical documentation connect radio evidence to medical-device risk and performance?
• Has regulatory review confirmed the current position immediately before market release?